These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 19120390)

  • 21. Systemic therapy of psoriasis using methotrexate.
    Smith KC
    Skin Therapy Lett; 2000; 6(3):1-2; 5. PubMed ID: 11176041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete reversion of anti-infliximab immunization by methotrexate combination in a patient with psoriasis.
    Vincent T; Best M; Plawecki M; Girard C
    J Dermatol; 2015 Oct; 42(10):1030-1. PubMed ID: 26119228
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate.
    Kirby B; Marsland AM; Carmichael AJ; Griffiths CE
    Clin Exp Dermatol; 2001 Jan; 26(1):27-9. PubMed ID: 11260172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab for the treatment of extensive plaque psoriasis--regulation, cost and reimbursement.
    Rabinovich M; Fainaru M
    Isr Med Assoc J; 2003 Nov; 5(11):817-8. PubMed ID: 14650110
    [No Abstract]   [Full Text] [Related]  

  • 25. Briakinumab versus Methotrexate for Psoriasis.
    Wu JJ
    N Engl J Med; 2012 Jan; 366(4):379-80; author reply 380. PubMed ID: 22276833
    [No Abstract]   [Full Text] [Related]  

  • 26. Briakinumab versus methotrexate for psoriasis.
    Malgarini RB; Pimpinella G
    N Engl J Med; 2012 Jan; 366(4):379; author reply 380. PubMed ID: 22276832
    [No Abstract]   [Full Text] [Related]  

  • 27. Current systemic therapies for psoriasis: where are we now?
    Yamauchi PS; Rizk D; Kormeili T; Patnaik R; Lowe NJ
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S66-77. PubMed ID: 12894129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of aseptic pleuropericarditis in a patient with chronic plaque psoriasis under methotrexate therapy.
    Savoia F; Gaddoni G; Casadio C; Patrizi A; Spadola G; Bassi P; Albertini F; Ballardini G; Briganti E; Casolari S; De Donà D; Menni B; Zanotti M; De Angelis P
    Dermatol Online J; 2010 Feb; 16(2):13. PubMed ID: 20178709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of ustekinumab in palmoplantar psoriasis.
    Bulai Livideanu C; Lahfa M; Mazereeuw-Hautier J; Paul C
    Dermatology; 2010; 221(4):321-3. PubMed ID: 20980724
    [No Abstract]   [Full Text] [Related]  

  • 30. Effective management of psoriasis symptom worsening during efalizumab therapy without discontinuing treatment: a case study.
    Gisondi P; Giglio MD; Girolomoni G
    J Dermatolog Treat; 2006; 17(3):172-5. PubMed ID: 16854760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Methotrexate therapy in psoriasis].
    Bournerias I
    Rev Prat; 2004 Jan; 54(1):52-5. PubMed ID: 15049601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term study of infliximab for psoriasis in daily practice: drug survival depends on combined treatment, obesity and infusion reactions.
    Spertino J; Lopez-Ferrer A; Vilarrasa E; Puig L
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1514-21. PubMed ID: 25493314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dercum's disease (adiposis dolorosa): a report of improvement with infliximab and methotrexate.
    Singal A; Janiga JJ; Bossenbroek NM; Lim HW
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):717. PubMed ID: 17448013
    [No Abstract]   [Full Text] [Related]  

  • 34. [Patient education. Information letter on treatment of psoriasis with infliximab (Remicade)].
    Groupe de recherche sur psoriasis de Société française de dermatologie, mai 2011
    Ann Dermatol Venereol; 2011 Dec; 138(12):865-7. PubMed ID: 22137633
    [No Abstract]   [Full Text] [Related]  

  • 35. Methotrexate in severe childhood psoriasis.
    Dogra S; Handa S; Kanwar AJ
    Pediatr Dermatol; 2004; 21(3):283-4. PubMed ID: 15165222
    [No Abstract]   [Full Text] [Related]  

  • 36. Cancer-free survival of psoriasis patients treated with methotrexate and cyclosporine combination.
    Aydin F; Yuksel EP; Senturk N; Canturk T; Turanli AY
    Cutan Ocul Toxicol; 2014 Sep; 33(3):181-3. PubMed ID: 23944659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Personal experience with the use of infliximab].
    Carretero G
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():36-42. PubMed ID: 19080990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is methotrexate safe in the treatment of psoriatic patients?
    Al-Waiz MM; Jafar SJ
    Saudi Med J; 2004 Apr; 25(4):536-7. PubMed ID: 15083237
    [No Abstract]   [Full Text] [Related]  

  • 39. [Infliximab].
    Goujon C; Bachelez H
    Ann Dermatol Venereol; 2011 Dec; 138(12):839-41. PubMed ID: 22137623
    [No Abstract]   [Full Text] [Related]  

  • 40. [Question of the month. Is there any risk of prescribing methotrexate in psoriasis, the use of which is not legally allowed in France?].
    Ann Dermatol Venereol; 1996; 123(12):861-4. PubMed ID: 9636783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.